drugset / Trial / NCT02746302
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial is conducted in China. The aim of this trial is to assess the safety and tolerability of HS-20004 in healthy Chinese subjects.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-01
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-20004 | Unknown | 0.02 mg | Subcutaneous |
| Subject | HS-20004 | Unknown | 0.04 mg | Subcutaneous |
| Subject | HS-20004 | Unknown | 0.05 mg | Subcutaneous |
| Subject | HS-20004 | Unknown | 0.06 mg | Subcutaneous |
| Subject | HS-20004 | Unknown | 0.08 mg | Subcutaneous |
| Subject | HS-20004 | Unknown | 0.1 mg | Subcutaneous |
Indications
No indication recorded.